SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 53 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $57,000 | 0.0% | 24,636 | 0.0% | 0.00% | – |
| Q4 2018 | $57,000 | -83.7% | 24,636 | +4.4% | 0.00% | -100.0% |
| Q3 2018 | $350,000 | -2.2% | 23,596 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $358,000 | -17.1% | 23,596 | +2.6% | 0.00% | 0.0% |
| Q1 2018 | $432,000 | +200.0% | 23,000 | +189.8% | 0.00% | – |
| Q4 2017 | $144,000 | -20.9% | 7,937 | -3.2% | 0.00% | – |
| Q3 2017 | $182,000 | – | 8,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Wealth Management, LLC | 180,552 | $36,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 122,942 | $24,000 | 0.00% |
| CITIGROUP INC | 1,739 | $0 | 0.00% |
| GOLDMAN SACHS GROUP INC | 52,553 | $11,000 | 0.00% |
| MORGAN STANLEY | 101 | $0 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 15,936 | $3,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 20 | $0 | 0.00% |
| BlackRock Inc. | 90,036 | $18,000 | 0.00% |
| Ballentine Partners, LLC | 16,700 | $3,000 | 0.00% |
| Citadel Advisors | 83,839 | $17,000 | 0.00% |